Related Experiment Video
Updated: May 21, 2026
07:49
Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Published on: April 13, 2015
Infiltrating CTLs are bothered by HLA-E on tumors.
Marloes J M Gooden1, Thorbald van Hall
1Department of Obstetrics & Gynecology; University Medical Center Groningen; University of Groningen; Groningen, The Netherlands.
Oncoimmunology
|June 22, 2012
Summary
High HLA-E expression in ovarian and cervical cancers inhibits cytotoxic T lymphocytes (CTLs), diminishing their survival benefit. This finding reveals a novel immune evasion mechanism in these cancers.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Human Leukocyte Antigen-E (HLA-E) has been observed to be upregulated in ovarian and cervical cancers.
- The role of HLA-E in cancer immunity is complex and warrants further investigation.
Purpose of the Study:
- To investigate the mechanism by which upregulated HLA-E affects the tumor microenvironment in ovarian and cervical cancers.
- To determine the interaction between HLA-E and immune cells, specifically cytotoxic T lymphocytes (CTLs).
Main Methods:
- Analysis of HLA-E expression in tumor samples.
- Investigation of the interaction between HLA-E and its receptor CD94/NKG2A on CTLs.
- Assessment of the impact of HLA-E expression on CTL infiltration and survival within the tumor microenvironment.
Main Results:
- Upregulated HLA-E in ovarian and cervical cancers was confirmed.
- HLA-E was found to inhibit intratumoral CTLs through the CD94/NKG2A receptor, rather than interacting with natural killer cells.
- The survival advantage conferred by intraepithelial infiltrating CTLs was abolished in tumors with high HLA-E expression.
Conclusions:
- HLA-E plays a critical role in immune evasion in ovarian and cervical cancers by suppressing CTL activity.
- Targeting the HLA-E/CD94-NKG2A pathway may represent a potential therapeutic strategy to enhance anti-tumor immunity.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...